BNET Industries

International Fight League Inc.

(IFLI) is in the Pharma Industry

Market Cap:$790.5K

Last Fiscal Year Sales:$5.6M

Public
US

Dow Jones Description

Since 2001, Paligent Inc. together with its subsidiaries (collectively, ?Paligent? or the ?Company?) has been engaged in seeking business opportunities to maximize value for its shareholders. The Company has evaluated various strategic alternatives, including acquisitions of new operating businesses and technologies as well as potential merger opportunities. From its inception in 1985 through 1999, the Company operated, under the name Procept, Inc., as a biotechnology company engaged in the development and commercialization of novel drugs with a product portfolio focused on infectious diseases and oncology. During 1999, the Company?s principal efforts were devoted to drug development and human clinical trials focusing on two biotechnology compounds, PRO 2000 Gel and O6-Benzylguanine (?O6-BG?). During fiscal 2000, the Company closed its research facilities and out-licensed PRO 2000 Gel and O6-BG, which had been under development by the Company for several years. In September 2004, the Company transferred all of its rights, title and interest in PRO 2000 Gel pursuant to an option duly exercised by its sublicensee and in March 2005, the Company assigned all of its rights, interests and obligations in O6-BG.

Director

Jeffrey M. Jagid

Contact Information

424 West 33rd Street, Suite 650

New York, New York 10001

212- 356-4000

Peer Companies

NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414

Executive Profiles

Decision Makers

Name (plus bio)	Position
Jeffrey M. Jagid	Director
Zola P. Horovitz	Director

Board of Directors

Name (plus bio)	Position
Richard J. Kurtz	Member of the Board of Directors

Organization	Position	Status
Ezwebadministration.Com	Chairman of the Board, Chief Executive Officer, and Director.	Current
I.D. Systems, Inc.	Chairman and Chief Executive Officer	Current
Coining Technologies, Inc.	Director	Current
International Fight League, Inc.	Director	Current
Tannenbaum Helpern Syracuse & Hirschtritt Llp	Corporate Litigation Associate	Former
I.D. Systems, Inc.	Director	Former
Benjamin N. Cardozo School of Law	Juris Doctor Degree	Former
Emory University	Bachelor of Business Administration	Former

Mr. Kurtz has been chief executive officer of the Kamson Corporation, a privately held corporation, for the past 30 years. The Kamson Corporation has its principal executive offices located in Englewood Cliffs, New Jersey and currently owns and operates eighty one (81) investment properties in the Northeastern U.S. Mr. Kurtz is a graduate of the University of Miami and a member of its President's Club. Most notably, the Chamber of Commerce in Englewood Cliffs and the Boy Scouts of America chose him Man of the Year. Mr. Kurtz resides in Alpine, New Jersey and is currently vice president and a member of the Board of Directors for the Jewish Community Center on the Palisades in Tenafly, New Jersey. He is also an elected member of the Board of Trustees and Foundation Board for the Englewood Hospital and Medical Center of New Jersey and the Board of Governors for the Jewish Home and Rehabilitation Center.

Organization	Position	Status
Kamson Corporation	Chief Executive Officer	Current
Lapolla Industries, Inc.	Chairman of the Board	Current
International Fight League, Inc.	Member of the Board of Directors	Current
University of Miami	President	Former
University of Miami	Member	Former

Organization	Position	Status
Sage Healthcare, Ltd.		Current
Phyton, Inc.	Chairman	Current
GenVec, Inc.	Chairman	Current
Immunicon Corporation	Chair	Current
Genaera Corporation	Chairman	Current
BioCryst Pharmaceuticals, Inc.	Director, Chairman of The Board	Current
Xintria Pharmaceutical Corporation	Member of Dov Pharmaceuticals Board of Directors	Current
Palatin Technologies Inc.	Board of Directors	Current
Avigen, Inc.	Director	Current
BioCryst Pharmaceuticals, Inc.	Director	Current
NitroMed, Inc.	Director	Current
International Fight League, Inc.	Director	Current
DOV Pharmaceutical, Inc.	Director	Current
Immunicon Corporation	Director	Current
NitroMed, Inc.	Committee Member	Current
Avigen, Inc.	Vice President, Business Development	Former
Bristol-Myers Squibb Company	Vice President, Business Development and Planning	Former
Bristol-Myers Squibb Company	Associate Director	Former
Bristol-Myers Squibb Company	Liaison	Former
Phyton, Inc.	Director	Former
Princeton University	Board of Directors	Former
GenVec, Inc.	Director	Former
University of Pittsburgh	Ph.D. In Pharmacology	Former
University of Pittsburgh	M.S. In Pharmacology	Former
University of Pittsburgh	B.S. In Pharmacy	Former